Trial Profile
A Prospective, Open-label, Parallel, Controlled Study to Evaluate the Efficacy of Fenofibrate on Microalbuminuria in Hypertriglyceridemic Patients With Type 2 Diabetes on Top of Statin Therapy
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fenofibrate (Primary)
- Indications Hypertriglyceridaemia; Proteinuria
- Focus Therapeutic Use
- 17 Dec 2014 New trial record